Axsome Therapeutics, Inc.

Historical 13F Holders

Symbol
AXSM
CUSIP
05464T104
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 383 37.1 M $4.33 B
2024 Q4 326 37.2 M $3.15 B
2024 Q3 311 38.5 M $3.46 B
2024 Q2 279 41.2 M $3.32 B
2024 Q1 288 40.8 M $3.25 B
2023 Q4 274 39.6 M $3.15 B
2023 Q3 254 37.9 M $2.65 B
2023 Q2 261 36.4 M $2.62 B
2023 Q1 221 31.9 M $1.97 B
2022 Q4 252 30.8 M $2.38 B
2022 Q3 219 25.8 M $1.15 B
2022 Q2 205 21.6 M $827 M
2022 Q1 199 19.1 M $793 M
2021 Q4 202 18.8 M $712 M
2021 Q3 202 19.1 M $627 M
2021 Q2 198 22.9 M $1.55 B
2021 Q1 204 23.1 M $1.31 B
2020 Q4 206 24.1 M $1.96 B
2020 Q3 196 24.1 M $1.71 B
2020 Q2 215 24.3 M $2.00 B
2020 Q1 198 22.9 M $1.35 B
2019 Q4 200 22.7 M $2.35 B
2019 Q3 125 18.9 M $387 M
2019 Q2 126 18.4 M $479 M
2019 Q1 83 14.8 M $216 M
2018 Q4 40 3.92 M $11.1 M
2018 Q3 36 3.53 M $12.2 M
2018 Q2 37 4.10 M $13.1 M
2018 Q1 37 4.23 M $10.4 M
2017 Q4 37 5.82 M $32.6 M
2017 Q3 31 6.01 M $33.3 M
2017 Q2 35 6.40 M $35.3 M
2017 Q1 51 7.77 M $30.3 M
2016 Q4 42 6.22 M $42.0 M
2016 Q3 36 6.31 M $49.7 M
2016 Q2 34 5.80 M $43.7 M
2016 Q1 17 5.26 M $45.2 M
2015 Q4 11 5.22 M $47.7 M